Preterm Birth Clinical Trial
— NeoUpOfficial title:
Interdisciplinary, E-health Based, Multimodal Follow-up of Somatic, Sleep-related and Psychological Symptoms of Very Immature Preterm Born Babies in Different Age Groups for the Further Development of Previous Care Structures
The aim of the study is to assess mental and somatic symptoms of preterm born children at the ages of 2, 5 and 10 by a multidisciplinary team and to evaluate an app that screens for these symptoms. Furthermore, there will be an evaluation of an intervention by our multidisciplinary team that provides recommendations for further treatment and diagnostic procedures of the children.
Status | Recruiting |
Enrollment | 90 |
Est. completion date | December 2024 |
Est. primary completion date | October 2024 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 2 Years to 10 Years |
Eligibility | Inclusion Criteria: - female and male preterm born children (<32 week of pregnancy) that are treated at the clinic in Tübingen and their parents - Existence of systematical neonatal data and consent of the care person to use this data - Existence of the data of the 2 year regular follow-up (for the 5 and 10 year olds) Exclusion Criteria: - lack of access to a mobile phone/tablet including internet access - insufficient knowledge of the German language of both parents |
Country | Name | City | State |
---|---|---|---|
Germany | University Hospital Tuebingen | Tuebingen |
Lead Sponsor | Collaborator |
---|---|
University Hospital Tuebingen |
Germany,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Bayley Scales of Infant and Toddler Development | IQ testing | Baseline | |
Primary | Wechsler Intelligence Scale for Children (WISC-V) | IQ testing | Baseline | |
Primary | Children's Sleep Habit Questionnaire (CSHQ-DE 4-10) | Screening of sleeping behaviour | Baseline and 36-38 weeks after baseline | |
Primary | Sleep Self Report (SSR) | Screening of sleeping behaviour | Baseline and 36-38 weeks after baseline | |
Primary | Somatics | Questions to somatic symptoms (diagnoses, inpatient stays, medication, early support) physical therapy, hearing impairment or visual disturbance, pulmonary symptoms, seizure disorders, health related quality of life, body weight, size) | Baseline and 36-38 weeks after baseline | |
Primary | Child Behavior Checklist (CBCL) | Screening for mental illness | Baseline and 36-38 weeks after baseline | |
Primary | Youth Self Report (YSR) | Screening for mental illness | Baseline and 36-38 weeks after baseline | |
Primary | Diagnostic-system for mental illness for children and adolescents - III (DISYPS-III SCREEN FBB and SBB) | Screening for mental illness | Baseline and 36-38 weeks after baseline | |
Primary | KIDSCREEN-27 (The KIDSCREEN) | Health related quality of life | Baseline and 36-38 weeks after baseline | |
Primary | Parent's Stress Inventory (EBI) | Load as parents and relationship to the child | Baseline and 36-38 weeks after baseline | |
Primary | App-questions | Questions reflecting the questionnaires | Baseline and 36-38 weeks after baseline | |
Primary | Postexperimental questionnaire | Evaluation of the study | 36-38 weeks after baseline | |
Secondary | Demographic data | age, gender, ethnicity, perinatal data from previous study participation | Baseline | |
Secondary | Actigraphy measurement | Device that the children are wearing at their wrists | Baseline | |
Secondary | Video of a sleeping sequence | The parents are taking a short video sequence of their sleeping child | Baseline | |
Secondary | Sleep cartoon for children | Cartoon sleep behavior | Baseline and 36-38 weeks after baseline | |
Secondary | Kiddie-Sads-Present and Lifetime Version (K-SADS PL) | Screening mental Illness | Baseline | |
Secondary | Self efficacy dealing with social situations (WIRKSOZ) | Self-efficacy measurement for social situations in children | Baseline and 36-38 weeks after baseline | |
Secondary | Group interviews | Group interviews with experts and families to get feedback about the study procedure and needs | Baseline and 36-38 weeks after baseline |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT05934318 -
L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE)
|
N/A | |
Completed |
NCT05502510 -
Assessing the Effectiveness and Efficacy of the MyHealthyPregnancy Application
|
||
Not yet recruiting |
NCT03418012 -
Prevention of sPTB With Early Cervical Pessary Treatment in Women at High Risk for PTB
|
N/A | |
Not yet recruiting |
NCT03418311 -
Cervical Pessary Treatment for Prevention of s PTB in Twin Pregnancies on Children`s Long-Term Outcome
|
N/A | |
Completed |
NCT02993744 -
Maternal Inflammatory Parameters Within Routine Treatment With Betamethasone
|
N/A | |
Active, not recruiting |
NCT02673216 -
Infection and Adverse Pregnancy Outcome
|
||
Completed |
NCT01683565 -
Preemie Tots: A Pilot Study to Understand the Effects of Prematurity in Toddlerhood
|
Phase 4 | |
Completed |
NCT01460576 -
Improving Prematurity-Related Respiratory Outcomes at Vanderbilt
|
N/A | |
Completed |
NCT01412931 -
Protein and Ultrasound Indicators of Preterm Birth
|
N/A | |
Completed |
NCT02606058 -
The Australian Placental Transfusion Study (APTS): Should Very Pre Term Babies Receive a Placental Blood Transfusion at Birth Via Deferring Cord Clamping Versus Standard Cord Clamping Procedures?
|
N/A | |
Terminated |
NCT03715530 -
Use of Placental Alpha Microglobulin-1(PAMG-1) to Diagnose Premature Rupture of Membranes in Pregnant Women
|
N/A | |
Completed |
NCT00422526 -
Progesterone for Prevention of Preterm Birth in Women With Short Cervix: Randomized Controlled Trial
|
Phase 3 | |
Enrolling by invitation |
NCT04251260 -
Effectiveness of Positioning in Preterm Neonates
|
N/A | |
Completed |
NCT03668860 -
India Dexamethasone and Betamethasone
|
Phase 1 | |
Recruiting |
NCT03638037 -
Correlation Between Maternal Vitamin D Level And Preterm Birth
|
||
Completed |
NCT02225353 -
Efficacy Study of a Cervical Pessary Containing Progesterone for the Prevention of Preterm Delivery
|
Phase 2 | |
Recruiting |
NCT03992534 -
The FLIP-1 Study: Vaginal Lactobacillus Supplementation in Women at High Risk of Preterm Birth
|
Phase 1 | |
Completed |
NCT03144141 -
Association Between EHG and Risk of Preterm Delivery in Women Hospitalized for Threatened Premature Delivery
|
N/A | |
Completed |
NCT05210985 -
Examination of the Relationship Between Home Affordances With Development
|
||
Completed |
NCT04021654 -
What is the Future of Vulnerable New-borns
|